Business
OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 4
OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 4.
About this update from Enigma Bulwark Ltd
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on the OTCQB® Venture Marketplace: Allied Resources, Inc. (OTCQB: ALOD) – Allied Resources is an oil and natural gas exploration, development and production company with interests in Texas and West Virginia. CardioGenics Holdings Inc. (OTCQB: CGNH) – Based in Ontario, Canada, CardioGenics is engaged in the development and marketing of a point of care testing device and several diagnostic test products. The point-of-care testing device is less expensive, easier to use, network ready, provides faster results, and provides lab-quality results within 15 minutes with large advantages over competing products on the market today, including improving patient outcomes and reducing costs associated with such healthcare. Delta International Oil & Gas Inc. (OTCQB: DLTZ) – Delta Mutual specializes in international energy recovery. It is an oil, gas and mining company with concessions in South America. Elite Pharmaceuticals, Inc. (OTCQB: ELTP) – Elite Pharmaceuticals is a specialty pharmaceutical company developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite owns generic and OTC products licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International with seven commercial products currently being sold, additional approved products pending manufacturing site transfer and a product under review pending approval by the FDA. Elite’s lead pipeline products include abuse-deterrent opioids utilizing the company’s patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.), and a Hong Kong based company to develop a branded product for the United States market and its...